Bitacura, Rebecca C.
HRN: 21-41-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2022
06/07/2022
IV
600 Mg
Q8H
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes